Prism Pharmaceuticals, Inc.
Records under this name other than patents Prism Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Prism Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,853,236 | Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,125,945 | Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,623,045 | Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,034,947 | Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,512,697 | Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,835,407 | Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,399,067 | Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,111,863 | Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,236,782 | Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same Formerly held In force · From the USPTO record | In force | From the USPTO record |